Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |